Tim
Sandle has written an article reviewing the changes to the USP chapter relating
to the environmental monitoring of areas used for the manufacture of sterile
products (chapter 1116, which was issued in the 35th edition of the
USP). The analysis is from a European
perspective.
The
main changes with the USP were:
To focus the chapter
on environmental monitoring only, by removing information relating to aseptic
process validation and to the physical aspects of cleanroom operations.
To focus the document
exclusively on the monitoring of aseptic environments, by removing references
to the monitoring of non-sterile environments.
To reconsider the
alert and action level (limit) concept.
The article has been published in the latest edition of the GMPReview. The reference is:
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources